1.           Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        Antibody Testing Market – By Products

1.3.2        Antibody Testing Market – By Indication

1.3.3        Antibody Testing Market – By End User

1.3.4        North America Antibody Testing Market – By Country

2.           North America Antibody Testing Market – Key Takeaways

3.        Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           North America Antibody Testing Market – Market Landscape

4.1         Overview

4.2         PEST Analysis

4.3         Expert Opinions

5.           North America Antibody Testing Market – Key Market Dynamics

5.1         Market Drivers

5.1.1        Rising Number of COVID-19 Cases

5.1.2        Increasing Prevalence of Chronic Diseases

5.1.3        Growing Geriatric Population

5.2         Market Restraints

5.2.1        Limitations of Antibody Screening Tests

5.3         Market Opportunities

5.3.1        Collaborative & Innovation-Driven Strategies

5.3.2        Growth of Healthcare Sector in Emerging Markets

5.4         Future Trends

5.4.1        Increasing Adoption and Popularity of Automation in Clinical Laboratories

5.5         Impact Analysis

6.           Antibody Testing Market – North America Analysis

6.1         North America Antibody Testing Marker Revenue Forecast and Analysis

7.           North America Antibody Testing Market Analysis and Forecasts to 2028 Product

7.1         Overview

7.2         North America Antibody Testing, by Products, 2021 & 2028 (% Share)

7.3         Kits

7.3.1        Overview

7.3.2        Kits: Antibody Testing Market – Revenue and Forecast to 2028 (USD Million)

7.3.2.1          Serological Test Kits

7.3.2.1.1          Overview

7.3.2.1.2          Serological Test Kits: Antibody Testing Market – Revenue and Forecast to 2028 (USD Million)

7.3.2.2          Immunoglobulin Kits

7.3.2.2.1          Overview

7.3.2.2.2          Immunoglobulin Kits: Antibody Testing Market – Revenue and Forecast to 2028 (USD Million)

7.3.2.3          Lateral Flow Assay Kits

7.3.2.3.1          Overview

7.3.2.3.2          Lateral Flow Assay Kits: Antibody Testing Market – Revenue and Forecast to 2028 (USD Million)

7.4         Chemical and Reagents

7.4.1        Overview

7.4.2        North America Chemical and Reagents Market Revenue and Forecast to 2028 (USD Million)

7.5         Consumables

7.5.1        Overview

7.5.2        North America Consumables Market Revenue and Forecast to 2028 (USD Million)

8.           North America Antibody Testing Market Analysis – By Indication

8.1         Overview

8.2         North America Antibody Testing Market Revenue Share, by Indication (2021 and 2028)

8.3         Infectious Diseases

8.3.1        Overview

8.3.2        Infectious Diseases: Antibody Testing Market – Revenue and Forecast to 2028 (USD Million)

8.3.2.1          Covid-19

8.3.2.1.1          Overview

8.3.2.1.2          Covid-19: Antibody Testing Market – Revenue and Forecast to 2028 (USD Million)

8.3.2.2          HIV

8.3.2.2.1          Overview

8.3.2.2.2          HIV: Antibody Testing Market – Revenue and Forecast to 2028 (USD Million)

8.3.2.3          Hepatitis

8.3.2.3.1          Overview

8.3.2.3.2          Hepatitis: Antibody Testing Market – Revenue and Forecast to 2028 (USD Million)

8.3.2.4          Tuberculosis

8.3.2.4.1          Overview

8.3.2.4.2          Tuberculosis: Antibody Testing Market – Revenue and Forecast to 2028 (USD Million)

8.3.2.5          Influenza

8.3.2.5.1          Overview

8.3.2.5.2          Influenza: Antibody Testing Market – Revenue and Forecast to 2028 (USD Million)

8.3.2.6          Human Papillomavirus (HPV)

8.3.2.6.1          Overview

8.3.2.6.2          Human Papillomavirus (HPV): Antibody Testing Market – Revenue and Forecast to 2028 (USD Million)

8.3.2.7          Others

8.3.2.7.1          Overview

8.3.2.7.2          Others: Antibody Testing Market – Revenue and Forecast to 2028 (USD Million)

8.4         Endocrine Diseases

8.4.1        Overview

8.4.2        Endocrine Diseases: Antibody Testing Market – Revenue and Forecast to 2028 (USD Million)

8.4.2.1          Diabetes

8.4.2.1.1          Overview

8.4.2.1.2          Diabetes: Antibody Testing Market – Revenue and Forecast to 2028 (USD Million)

8.4.2.2          Thyroid Disorders

8.4.2.2.1          Overview

8.4.2.2.2          Thyroid Disorders: Antibody Testing Market – Revenue and Forecast to 2028 (USD Million)

8.4.2.3          Others

8.4.2.3.1          Overview

8.4.2.3.2          Others: Antibody Testing Market – Revenue and Forecast to 2028 (USD Million)

8.5         Oncology

8.5.1        Overview

8.5.2        Oncology: Antibody Testing Market – Revenue and Forecast to 2028 (USD Million)

8.5.2.1          Breast Cancer

8.5.2.1.1          Overview

8.5.2.1.2          Breast Cancer: Antibody Testing Market – Revenue and Forecast to 2028 (USD Million)

8.5.2.2          Melanoma

8.5.2.2.1          Overview

8.5.2.2.2          Melanoma: Antibody Testing Market – Revenue and Forecast to 2028 (USD Million)

8.5.2.3          Gastric Cancer

8.5.2.3.1          Overview

8.5.2.3.2          Gastric Cancer: Antibody Testing Market – Revenue and Forecast to 2028 (USD Million)

8.5.2.4          Others

8.5.2.4.1          Overview

8.5.2.4.2          Others: Antibody Testing Market – Revenue and Forecast to 2028 (USD Million)

8.6         Cardiovascular Diseases

8.6.1        Overview

8.6.2        Cardiovascular Diseases: Antibody Testing Market – Revenue and Forecast to 2028 (USD Million)

8.7         Pregnancy

8.7.1        Overview

8.7.2        Pregnancy: Antibody Testing Market – Revenue and Forecast to 2028 (USD Million)

8.8         Autoimmune Diseases

8.8.1        Overview

8.8.2        Autoimmune Diseases: Antibody Testing Market – Revenue and Forecast to 2028 (USD Million)

8.8.2.1          Rheumatoid Arthritis

8.8.2.1.1          Overview

8.8.2.1.2          Rheumatoid Arthritis: Antibody Testing Market – Revenue and Forecast to 2028 (USD Million)

8.8.2.2          Inflammatory Bowel Disease

8.8.2.2.1          Overview

8.8.2.2.2          Inflammatory Bowel Disease: Antibody Testing Market – Revenue and Forecast to 2028 (USD Million)

8.8.2.3          Multiple Sclerosis

8.8.2.3.1          Overview

8.8.2.3.2          Multiple Sclerosis: Antibody Testing Market – Revenue and Forecast to 2028 (USD Million)

8.8.2.4          Others

8.8.2.4.1          Overview

8.8.2.4.2          Others: Antibody Testing Market – Revenue and Forecast to 2028 (USD Million)

8.9         Other Diseases

8.9.1        Overview

8.9.2        Other Diseases: Antibody Testing Market – Revenue and Forecast to 2028 (USD Million)

9.           North America Antibody Testing Market – By End User

9.1         Overview

9.2         Antibody Testing Market, by End User, 2021 and 2028 (%)

9.3         Diagnostic Laboratories

9.3.1        Overview

9.3.2        North America Diagnostic Laboratories Market Revenue and Forecast to 2028 (USD Million)

9.4         Hospitals

9.4.1        Overview

9.4.2        North America Hospitals Market Revenue and Forecast to 2028 (USD Million)

9.5         Biopharmaceutical Companies

9.5.1        Overview

9.5.2        North America Biopharmaceutical Companies: Antibody Testing Market – Revenue and Forecast to 2028 (USD Million)

9.6         Academic and Research Institutes

9.6.1        Overview

9.6.2        North America, Academic and Research Institutes: Antibody Testing Market – Revenue and Forecast to 2028 (USD Million)

10.        North America Antibody Testing Market Analysis and Forecasts To 2028 Country Analysis

10.1      North America: Antibody Testing Market

10.1.1     Overview

10.1.2     North America: Antibody Testing Market, by Country, 2021 & 2028 (%)

10.1.2.1       US: Antibody Testing Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.1.1       US: Antibody Testing Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.1.2       US: Antibody Testing Market, by Products – Revenue and Forecast to 2028 (USD Million)

10.1.2.1.2.1     US: Antibody Testing Market, by Kits – Revenue and Forecast to 2028 (USD Million)

10.1.2.1.3       US: Antibody Testing Market, by Indication – Revenue and Forecast to 2028 (USD Million)

10.1.2.1.3.1     US: Antibody Testing Market, by Infectious Diseases – Revenue and Forecast to 2028 (USD Million)

10.1.2.1.3.2     US: Antibody Testing Market, by Endocrine Diseases – Revenue and Forecast to 2028 (USD Million)

10.1.2.1.3.3     US: Antibody Testing Market, by Oncology – Revenue and Forecast to 2028 (USD Million)

10.1.2.1.3.4     US: Antibody Testing Market, by Autoimmune Diseases – Revenue and Forecast to 2028 (USD Million)

10.1.2.1.4       US: Antibody Testing Market, by End User – Revenue and Forecast to 2028 (USD Million)

10.1.2.2       Canada: Antibody Testing Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.2.1       Canada: Antibody Testing Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.2.2       Canada: Antibody Testing Market, by Products – Revenue and Forecast to 2028 (USD Million)

10.1.2.2.2.1     Canada: Antibody Testing Market, by Kits – Revenue and Forecast to 2028 (USD Million)

10.1.2.2.3       Canada: Antibody Testing Market, by Indication – Revenue and Forecast to 2028 (USD Million)

10.1.2.2.3.1     Canada: Antibody Testing Market, by Infectious Diseases – Revenue and Forecast to 2028 (USD Million)

10.1.2.2.3.2     Canada: Antibody Testing Market, by Endocrine Diseases – Revenue and Forecast to 2028 (USD Million)

10.1.2.2.3.3     Canada: Antibody Testing Market, by Oncology – Revenue and Forecast to 2028 (USD Million)

10.1.2.2.3.4     Canada: Antibody Testing Market, by Autoimmune Diseases – Revenue and Forecast to 2028 (USD Million)

10.1.2.2.4       Canada: Antibody Testing Market, by End User – Revenue and Forecast to 2028 (USD Million)

10.1.2.3       Mexico: Antibody Testing Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.3.1       Mexico: Antibody Testing Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.3.2       Mexico: Antibody Testing Market, by Products – Revenue and Forecast to 2028 (USD Million)

10.1.2.3.2.1     Mexico: Antibody Testing Market, by Kits – Revenue and Forecast to 2028 (USD Million)

10.1.2.3.3       Mexico: Antibody Testing Market, by Indication – Revenue and Forecast to 2028 (USD Million)

10.1.2.3.3.1     Mexico: Antibody Testing Market, by Infectious Diseases – Revenue and Forecast to 2028 (USD Million)

10.1.2.3.3.2     Mexico: Antibody Testing Market, by Endocrine Diseases – Revenue and Forecast to 2028 (USD Million)

10.1.2.3.3.3     Mexico: Antibody Testing Market, by Oncology – Revenue and Forecast to 2028 (USD Million)

10.1.2.3.3.4     Mexico: Antibody Testing Market, by Autoimmune Diseases – Revenue and Forecast to 2028 (USD Million)

10.1.2.3.4       Mexico: Antibody Testing Market, by End User – Revenue and Forecast to 2028 (USD Million)

11.        North America Industry Landscape

11.1      Overview

11.2      Growth Strategies Done by the Companies in the Market, (%)

11.3      Organic Developments

11.3.1     Overview

11.4      Inorganic Developments

11.4.1     Overview

12.        Company Profiles

12.1      THERMO FISHER SCIENTIFIC INC.

12.1.1     Key Facts

12.1.2     Business Description

12.1.3     Products and Services

12.1.4     Financial Overview

12.1.5     SWOT Analysis

12.1.6     Key Developments

12.2      Abbott

12.2.1     Key Facts

12.2.2     Business Description

12.2.3     Products and Services

12.2.4     Financial Overview

12.2.5     SWOT Analysis

12.2.6     Key Developments

12.3      BIO-RAD LABORATORIES INC.

12.3.1     Key Facts

12.3.2     Business Description

12.3.3     Products and Services

12.3.4     Financial Overview

12.3.5     SWOT Analysis

12.3.6     Key Developments

12.4      BD

12.4.1     Key Facts

12.4.2     Business Description

12.4.3     Products and Services

12.4.4     Financial Overview

12.4.5     SWOT Analysis

12.4.6     Key Developments

12.5      F. HOFFMANN-LA ROCHE LTD.

12.5.1     Key Facts

12.5.2     Business Description

12.5.3     Products and Services

12.5.4     Financial Overview

12.5.5     SWOT Analysis

12.5.6     Key Developments

12.6      Agilent Technologies, Inc.

12.6.1     Key Facts

12.6.2     Business Description

12.6.3     Products and Services

12.6.4     Financial Overview

12.6.5     SWOT Analysis

12.6.6     Key Developments

12.7      DiaSorin S.p.A.

12.7.1     Key Facts

12.7.2     Business Description

12.7.3     Products and Services

12.7.4     Financial Overview

12.7.5     SWOT Analysis

12.7.6     Key Developments

12.8      ZEUS Scientific

12.8.1     Key Facts

12.8.2     Business Description

12.8.3     Products and Services

12.8.4     Financial Overview

12.8.5     SWOT Analysis

12.8.6     Key Developments

12.9      Abcam plc

12.9.1     Key Facts

12.9.2     Business Description

12.9.3     Products and Services

12.9.4     Financial Overview

12.9.5     SWOT Analysis

12.9.6     Key Developments

12.10   Trinity Biotech

12.10.1  Key Facts

12.10.2  Business Description

12.10.3  Products and Services

12.10.4  Financial Overview

12.10.5  SWOT Analysis

12.10.6  Key Developments

13.        Appendix

13.1      About The Insight Partners

13.2      Glossary of Terms

LIST OF TABLES

Table 1.             Total Number of Persons Aged 60 Years or Above – by Country, 2017 & 2050

Table 2.             US: Antibody Testing Market, by Products – Revenue and Forecast to 2028 (USD Million)

Table 3.             US: Antibody Testing Market, by Kits – Revenue and Forecast to 2028 (USD Million)

Table 4.             US: Antibody Testing Market, by Indication – Revenue and Forecast to 2028 (USD Million)

Table 5.             US: Antibody Testing Market, by Infectious Diseases – Revenue and Forecast to 2028 (USD Million)

Table 6.             US: Antibody Testing Market, by Endocrine Diseases – Revenue and Forecast to 2028 (USD Million)

Table 7.             US: Antibody Testing Market, by Oncology – Revenue and Forecast to 2028 (USD Million)

Table 8.             US: Antibody Testing Market, by Autoimmune Diseases – Revenue and Forecast to 2028 (USD Million)

Table 9.             US: Antibody Testing Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 10.          Canada: Antibody Testing Market, by Products – Revenue and Forecast to 2028 (USD Million)

Table 11.          Canada: Antibody Testing Market, by Kits – Revenue and Forecast to 2028 (USD Million)

Table 12.          Canada: Antibody Testing Market, by Indication – Revenue and Forecast to 2028 (USD Million)

Table 13.          Canada: Antibody Testing Market, by Infectious Diseases – Revenue and Forecast to 2028 (USD Million)

Table 14.          Canada: Antibody Testing Market, by Endocrine Diseases – Revenue and Forecast to 2028 (USD Million)

Table 15.          Canada: Antibody Testing Market, by Oncology – Revenue and Forecast to 2028 (USD Million)

Table 16.          Canada: Antibody Testing Market, by Autoimmune Diseases – Revenue and Forecast to 2028 (USD Million)

Table 17.          Canada: Antibody Testing Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 18.          Mexico: Antibody Testing Market, by Products – Revenue and Forecast to 2028 (USD Million)

Table 19.          Mexico: Antibody Testing Market, by Kits – Revenue and Forecast to 2028 (USD Million)

Table 20.          Mexico: Antibody Testing Market, by Indication – Revenue and Forecast to 2028 (USD Million)

Table 21.          Mexico: Antibody Testing Market, by Infectious Diseases – Revenue and Forecast to 2028 (USD Million)

Table 22.          Mexico: Antibody Testing Market, by Endocrine Diseases – Revenue and Forecast to 2028 (USD Million)

Table 23.          Mexico: Antibody Testing Market, by Oncology – Revenue and Forecast to 2028 (USD Million)

Table 24.          Mexico: Antibody Testing Market, by Autoimmune Diseases – Revenue and Forecast to 2028 (USD Million)

Table 25.          Mexico: Antibody Testing Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 26.          Organic Developments Done By Companies

Table 27.          Inorganic Developments Done By Companies

Table 28.          Glossary of Terms, North America Antibody Testing Market

LIST OF FIGURES

Figure 1.           North America Antibody Testing Market Segmentation

Figure 2.           North America Antibody Testing Market – By Country

Figure 3.           North America Antibody Testing Market Overview

Figure 4.           North America Kits Product Segment Held Largest Share of Antibody Testing Market

Figure 5.           North America Antibody Testing Market, by Country (USD Million)

Figure 6.           North America PEST Analysis

Figure 7.           North America Antibody Testing Market Impact Analysis of Driver and Restraints

Figure 8.           North America Antibody Testing Market – Revenue Forecast And Analysis – 2020- 2028

Figure 9.           North America Antibody Testing, By Products, 2021 & 2028 (% Share)

Figure 10.        North America Kits: Antibody Testing Market – Revenue and Forecast to 2028 (USD Million)

Figure 11.        North America Serological Test Kits: Antibody Testing Market – Revenue and Forecast to 2028 (USD Million)

Figure 12.        North America Immunoglobulin Kits: Antibody Testing Market – Revenue and Forecast to 2028 (USD Million)

Figure 13.        North America Lateral Flow Assay Kits: Antibody Testing Market – Revenue and Forecast to 2028 (USD Million)

Figure 14.        North America Chemical and Reagents Market Revenue and Forecast to 2028 (USD Million)

Figure 15.        North America Consumables Market Revenue and Forecast to 2028 (USD Million)

Figure 16.        North America Antibody Testing Market Revenue Share, by Indication (2021 and 2028)

Figure 17.        North America Infectious Diseases: Antibody Testing Market – Revenue and Forecast to 2028 (USD Million)

Figure 18.        North America Covid-19: Antibody Testing Market – Revenue and Forecast to 2028 (USD Million)

Figure 19.        North America HIV: Antibody Testing Market – Revenue and Forecast to 2028 (USD Million)

Figure 20.        North America Hepatitis: Antibody Testing Market – Revenue and Forecast to 2028 (USD Million)

Figure 21.        North America Tuberculosis: Antibody Testing Market – Revenue and Forecast to 2028 (USD Million)

Figure 22.        North America Influenza: Antibody Testing Market – Revenue and Forecast to 2028 (USD Million)

Figure 23.        North America Human Papillomavirus (HPV): Antibody Testing Market – Revenue and Forecast to 2028 (USD Million)

Figure 24.        North America Others: Antibody Testing Market – Revenue and Forecast to 2028 (USD Million)

Figure 25.        North America Endocrine Diseases: Antibody Testing Market – Revenue and Forecast to 2028 (USD Million)

Figure 26.        North America Diabetes: Antibody Testing Market – Revenue and Forecast to 2028 (USD Million)

Figure 27.        North America Thyroid Disorders: Antibody Testing Market – Revenue and Forecast to 2028 (USD Million)

Figure 28.        North America Others: Antibody Testing Market – Revenue and Forecast to 2028 (USD Million)

Figure 29.        North America Oncology: Antibody Testing Market – Revenue and Forecast to 2028 (USD Million)

Figure 30.        North America Breast Cancer: Antibody Testing Market – Revenue and Forecast to 2028 (USD Million)

Figure 31.        North America Melanoma: Antibody Testing Market – Revenue and Forecast to 2028 (USD Million)

Figure 32.        North America Gastric Cancer: Antibody Testing Market – Revenue and Forecast to 2028 (USD Million)

Figure 33.        North America Others: Antibody Testing Market – Revenue and Forecast to 2028 (USD Million)

Figure 34.        North America Cardiovascular Diseases: Antibody Testing Market – Revenue and Forecast to 2028 (USD Million)

Figure 35.        North America Pregnancy: Antibody Testing Market – Revenue and Forecast to 2028 (USD Million)

Figure 36.        North America Autoimmune Diseases: Antibody Testing Market – Revenue and Forecast to 2028 (USD Million)

Figure 37.        North America Rheumatoid Arthritis: Antibody Testing Market – Revenue and Forecast to 2028 (USD Million)

Figure 38.        North America Inflammatory Bowel Disease: Antibody Testing Market – Revenue and Forecast to 2028 (USD Million)

Figure 39.        North America Multiple Sclerosis: Antibody Testing Market – Revenue and Forecast to 2028 (USD Million)

Figure 40.        North America Others: Antibody Testing Market – Revenue and Forecast to 2028 (USD Million)

Figure 41.        North America Other Diseases: Antibody Testing Market – Revenue and Forecast to 2028 (USD Million)

Figure 42.        North America Antibody Testing Market, by End User, 2021 and 2028 (%)

Figure 43.        North America Diagnostic Laboratories Market Revenue And Forecast To 2028 (USD Million)

Figure 44.        North America Hospitals Market Revenue And Forecast To 2028 (USD Million)

Figure 45.        North America Biopharmaceutical Companies: Antibody Testing Market – Revenue and Forecast to 2028 (USD Million)

Figure 46.        North America, Academic and Research Institutes: Antibody Testing Market – Revenue and Forecast to 2028 (USD Million)

Figure 47.        North America: Antibody Testing Market, by Key Country – Revenue (2021) (USD Million)

Figure 48.        North America: Antibody Testing Market, by Country, 2021 & 2028 (%)

Figure 49.        US: Antibody Testing Market – Revenue and Forecast to 2028 (USD Million)

Figure 50.        Canada: Antibody Testing Market – Revenue and Forecast to 2028 (USD Million)

Figure 51.        Mexico: Antibody Testing Market – Revenue and Forecast to 2028 (USD Million)

Figure 52.        Growth Strategies Done by the Companies in the Market, (%)